|| Home || Contact Us || Thyroid & Thyrotoxicosis || Hypothyroidism  || Goitre (Enlarged Thyroid)||  || Diabetes || 
|| Symptoms of Diabetes  || Diabetes Tt  || Monitoring of Diabetes || in Diabetes || 
|| Short Height Causes || Short ht.Treat || Obesity Causes Treatment  || Male Horm. DIS. ||  
|| Less Beard & Moustaches  || Small Testis || Hypogonadism || Andropause|| Testosterone Deficiency || 
|| Absent genital Development || Under Weight   || Gynecomastia (Breast Enlargement) || Breast Enlar Gement || 
|| Low Sprem Count  || Nil Sperm || Male Infertility ||SmallBreast || Menopause|| Facial Hair || Menstrual Irreg. ||
 || Fem.Horm Dis.|| Milk Secr./High Prolaction || Pituitary Gland || Clinic Map|| Online Enquiry || H. F.Causes ||
|| H. F. Diag || H. F. Tt || 

Some important information: Small Testis (small testis) enlargement/ enlarging/ growth/   treatment therapy by hormone therapy  is one of the very remarkable advancement in the last 5 years. Small Testis (small testis)   investigation, cause diagnosis & treatment facilities are availalable at very few centres in the delhi/ Delhi ( India / india).treatment of thousands patients has been successfully done at our centre. Small Testis (small testis) treatment therapy by hormone therapy is very successful. Small Testis (small testis) enlargement/ enlarging/ growth/   treatment therapy by hormone therapy after finding the correct cause of Small Testis (small testis). Small Testis (small testis) enlargement/ enlarging/ growth/    treatment therapy by hormone therapy medical treatment results are very good. After Small Testis (small testis) enlargement/ enlarging/ growth/ treatment therapy by hormone therapy patient becomes more satisfied. We have treatment for Small Testis (small testis) enlargement/ enlarging/ growth/ treatment therapy by hormone therapy. Before starting treatment for Small Testis (small testis) enlargement/ enlarging/ growth/   , our team of doctors decide how to treat Small Testis (small testis) enlargement/ enlarging/ growth/  . At our Delhi (India) center, we have highly qualified expert doctor, who are well trained in diagnosis of cause of Small Testis (small testis) . At our Delhi (India) centre, our doctors are experienced in Small Testis (small testis) enlargement/ enlarging/ growth/   treatment & therapy of Male/ male hormone deficiency hypogonadism/ Hypogonadism  . Small Testis (small testis) enlargement/ enlarging/ growth/  is done by drug (medical) treatment. Small Testis (small testis) enlargement/ enlarging/ growth/   is one of the common cause of inferiority complex in many boys & men. Small Testis (small testis) enlargement/ enlarging/ growth/   treatments is must. Male/ male hormone deficiency hypogonadism/ Hypogonadism  therapy can be by oral hormone pills. Male/ male hormone deficiency hypogonadism/ Hypogonadism  cause ( causes)  are investigated at our hospital. Male/ male hormone deficiency hypogonadism/ Hypogonadism  occurs due to various causes as mentioned above. Patient with Small Testis (small testis)   should go to qualified specialist. Small Testis (small testis)   patient should be investigated (various investigations / investigation ) before starting treatment. Our Hospital / centre is situated in east, East ,new,New, Delhi (India). It is closer to Central, central delhi, four kilometer from  South, south delhi , North, north delhi, &  West, west, delhi.  Our Delhi centre is eight kilometer from Noida, Noida, Gaziabad, ghaziabad, Faridabad, faridabad & Gurgaon, gurgaon. Our hospital/ centre is one of the most famous Small Testis (small testis) enlargement/ enlarging/ growth/ enlargement center in Delhi & India.

 Maturity-onset diabetes  youth (MODY) mental symptoms , metabolic acidosis , metabolic control ,  complications,  diabetic nephropathy,  dyslipidemia, evaluation , exercise , goals ,  children,  plasma lipoprotein levels, microangiopathy   infant  child, insulin-like growth factors , missed diagnosis , mortality rate , mucormycosis , mycocardial infarction , natural history , necrotizing fascitis , neonatal, neurogenic bladder , neuromuscular manifestations , nonalcoholic steatohepatitis , nutritional management ,  Diabetes mellitus, dietary therapy  obesity , body-fat distribution ,  elderly, genetics , lipids , ocular manifestations , oral contraceptives , oral / dental health , otolaryngologic effects , pancreoprivic, pathogenesis , environmental factors , events , genetic factors , initiation factors , progression factors , pathophysiology , pentamidine-induced, periarticular disease , peripheral vascular disease , phagocytic cell dysfunction , with pheochromocytoma, postpancreatectomy,  postpartum thyroiditis, pregestational,  pregnancy,   Diabetes mellitus, maternal; Gestational diabetes prevalence , age , geographic variation , prevention , breast-feeding , diet  exercise programs , progestin-only contraceptives , prognosis , prolactin secretion , protein metabolism , pseudoscleroderma , pyelonephritis , race / ethnicity , reflex sympathetic dystrophy , renal failure with  insulin requirements,  insulin therapy, renin-angiotensin system activity , respiratory effects , rheumatic manifestations , rhinocerrebral mucormycosis , risk factors , secondary forms , causes , complications , definition , dermatologic findings , with glucagonoma, with hormone overproduction,  infant  child, with insulin underproduction, with pheochromocytoma, treatment ,  genital function, sick-day rules , skiin , infectious complications , nonifectious complications , small bowel          complications , with somatostatinoma, sugar substitutes , susceptibility , genetics ,  taste sense, T cells ,  testicular failure, thigh muscle infarction , thyroid-stimulating hormone secretion , tobacco use , toxins , treatment ,   Insulin therapy dermatologic complications ,  dyslipidemia,  elderly, goals , hepatotoxicity ,  infant  child, insulin-induced hypoglycemia , intensive,  children,  retinopathy, nutritional support ,  pregnancy, psychosocial factors , regimen , selection ,  retinopathy, team approach ,  children, thymosin , tropical, tuberculosis , type 1 (insulin-dependent),  Addison disease,  adolescence, management , psychosocial factors , age at onset , amyloidosis , animal models , genetics , atpical, autoimmune character ,  autoimmune polyglandular failure, B-cell mass , biliary lipid secretion , bone loss , cardiovascular disease , causes  death ,  celiac disease, classification , clinical course , early, clinical presentation ,  adult, complications  distribution , late, congenital rubella , continuous subcutaneous insulin infusion (CSII) , cow’s milk proteins , delayed puberty , development , stages , diabetic ketoacidosis , precipitating factors , dietary therapy ,  childhood  adolescence,  pregnancy, duration ,  incidence  complications, early, first-phase insulin secretion as index , enteroviruses , environmental factors , epidemiology , etiology , fatty liver , genetics , glucagon , glucose homeostasis , HLA associations, hypertension , hypoglycemia ,  infant  child, IGF-I abnormalities , IL-1 , immune phenomena , immunology , immunotherapy , incidence ,  adolescents, age-specific,  children,  elderly, geographic variation , secular trend ,  infant  child, emotional support , exercise program , hypoglycemia , management , microvascular complications , psychosocial factors , insulin requirements , insulin therapy forl,   Insulin therapy islet cell antibodies , islet morphology , islet transplantation  immune attack , rejection , lipoprotein abnormalities , liver disease , major histocompatibility complex , metabolic control   dyslipidemia, goals ,  children,  plasma lipoprotein levels, microvascular complications ,  infant  child, missed diagnosis , mortality rate , natural history ,  obesity,  pregnancy, oral contraceptives , organ-specific defect           immunosuppression , organ-specific disorders associated with, pathogenesis , environmental factors , genetic factors , pathophysiology , pregestational, prevalence , geographic variation , prevention , breast-feeding , prodrome , prolactin , prolactin secretion , “3 P’s” , relapse stage , remission from, partial, total, retinopathy ,         rheumatoid ,  rheumatoid arthritis, screening , sick-day rules , simultaneous kidney/ pancreas transplantation , suppressor T-cells , survival rates , gender-specific, susceptibility , genetics , T cells , total, transient neonatal, treatment ,   Insulin therapy  dyslipidemia, goals ,  infant  child,  pregnancy, psychosocial factors , regimen , selection ,  retinopathy, team approach ,  children, thymosin , type 1A, autoimmunity , congenital rubella , environmental factors , genetic factors , immunologic abnormalities , immunotherapy , onset ,      prediction , pathogenesis , type 1B,  type 1 polyglandular syndrome, viral infections , type 2 (non-insulin-dependent), age , amyloid , animal models , thiazolidinedione therapy , arsenic poisoning , autoimmune phenomena , B-cell mass , biliary lipid secretion , candidate gene research , cardiovascular disease ,  cirrhosis, drug therapy , experimental strategies ,  elderly, epidemiology , exercise , familial distribution ,  familial dyslipidemia, fatty liver  histology , obesity , prevalence , first-phase insulin secretion , gallstones , obesity , genetics , glucose-dependent insulinotropic polypeptide , glucose homeostasis , hyperglycemia , hypertension , incidence , age-specific,  infant  child, insulin-receptor kinase activity , insulin requirements , insulin resistance , insulin secretion , linkage studies , lipoprotein abnormalities , liver disease , maternal inheritance , mitochondrial DNA , monigenic, nonedocrine organ-specific disorders associated with, obesity , pathogenesis , events , initiation factors , progression factors , pathophysiology , polygenic, pregestational, prevalence , age , geographic variation , prodrome , race / ethnicity , risk factors , somatostatin , susceptibility , genetics ,  syndrome X,           differentiation ,  trace minerals, treatment , BIDS (bedtime insulin  daytime Sulfonylurea(s) regimen ,  dyslipidemia, goals , intensive, oral agents , weight reduction , zinc deficiency ,  type 1 polyglandular          syndrome, undiagnosed, prevalence , urinary tract infection  bacterial, fungal, treatment , urine testing , vascular complications , cirrhosis , with VIPoma, viral infections , vitamin C , vitamin E ,  45, X syndrome, Diabetes Prevention Trial-1, Diabetic amyotrophy, Diabetic coma, ocular effects , Diabetic cystopathy, Diabetic diarrhea, Diabetic foot, arteriovenous shuting ,  gangrene, infection , limb-threatening, ischemia , management , neuropathy , osteomyelitis with, pathophysiology , patient education  responsibility , prevalence , prevenative measures , importance , ulcers , therapy , vascular reconstruction , Diabetic gastroparesis, treatment , Diabetic gastropathy, Diabetic hand, treatment , Diabetic hyperosmolar nonketotic coma, Diabetic ketoacidosis, carbohydrate metabolism , erebral edema ,  children, creatinine measurement , definition , diagnosis , diagnosis , differential diagnosis , epidemiology , exercise , fat metabolism , gastrointestinal manifestations , hematologic effects , hypophosphatemia , illness-related, incidence , world wide variability , infection , ketoaciduria , laboratory assessment , mortality rate , pathophysiology ,  pediatric patients, precipitating factors ,              prostaglandins , protein metabolism , pulmonary embolism , recurrent, respiratory effects , signs  symptoms , treatment , adult respiratory distress syndrome , bicarbonate , cerebral edema , clinical measures ,           complications , fluid overload , fluid replacement , hyperkalemia , hypernatremia , hypoglycemia , hypokalemia , insulin resistance , insulin therapy , intramuscular regimen , intravenous regimens , monitoring , potassum , respiratory effects , secondary phase , thromboembolic episodes , Diabetic maculopathy,  diabetic retinopathy, Diabetic nephropathy, clinical correlations , clinical course , diabetic neuropathy ,  diabetic retinopathy,         interrelations , dialysis , dyslipidemia , edema ,  elderly, epidemiology , glomerular filtration rate , glucosuria ,  hypertension, treatment , incidence , incipient,  infant  child, laboratory abnormalities , pancreas transplantation , papillary necrosis , pathogenesis , pregnancy , protein restriction , proteinuria , staging , tubulointerstitial disease , vascular involvement , Diabetic neuropathic cachexia,  elderly, Diabetic neuropathy, autonomic, cardiovascular, clinical characterisitcs , gastrointestinal involvement , sudomotor dysfunction , classification , clinical syndromes , cranial neropathy , definition ,  diabetic neuropathy, differential diagnosis , distal motor, distal         symmetric polyneuropathy, complications , differential diagnosis , treatment ,  elderly, elctrophysioloty , focal, foot problems due , gastrointestinal involvement ,  infant  child, intercostal, mononeuropathy, multifocal,  multifocal, painful drug therapy , treatment , pancreas transplantation , pathogenesis , pathology, plexopathy, with predominately large-fiber involvement, prevalence , radiculopathy, sensorimotor  autonomic (“mixed”), sensory, with predominately small-fiber involvement,  skiin, substance P , subclinical, treatment , nerve growth factor , Diabetic ophthalmoplegia, clinical features , prognosis , treatment , Diabetic polyradiculopathy, Diabetic retinopathy (DR) abdreviations associated with, age at onset  diabetes , background, classification , clinical features , diabetic maculopathy ,  diabetic nephropathy, interreration ,  elderly, exercise , follow-up , glaucoma ,  hemochromatosis, incidence ,  infant  child, involutional, nonproliferative, outcome , pancreas transplentation ,  pancreatic diabetes, pathology , pregnancy , preproliferative, clinical features , incidence , nephropathy  prognosis , treatment , puberty , risk factors , transitional, clinical features , prognosis , treatment , catacract surgery , photocoagulation , vitrectomy , Diabetic Retinopathy Study (DRS), Diabetic Retinopathy Vitrectomy Study (DRVS), Diabinese.  Chlorpropamide Diacylglycerol (DAG),  mast cell activation, metabolism , PTH ,  preimplantation embryo,  stimulus-secretion coupling, Diacylglycerol lipase, Diakinesis,  meiosis, Dialysis encerphalopathy, aluminum toxicity , Dialysis patient(s) aluminum accumulation , anemia , recombinant             erythropoietin ,  bone disease , cutaneous calcification , dental / orofacial obnormalities , diabetic, insulin          requirements , endocrine dysfunction , erythropoietin therapy , hypercalcemia , hypoglycemia , insulin therapy , vita2- microglobulin ,  bone, neuromuscular manifestations , osteomalacia , protein administration , guidelines , Diamine oxidase, activity , Diane  acne,  hirsutism, Diapause, Diaphram (contraceptive), effectiveness , popularity , Diaphragma sellae, anatomic defects , anatomy , radiographic anatomy , Diapid.  Lypressin Diarrhea  abetalipoproteinemia,  adrenal insufficiency,  chylomicron retention disease, diabetic, with glucagonoma,  hyperthyroidism, hypoparathyroidism ,  hypothyroidism, magnesium loss , with medullary thyroid carcinoma, octreotide , with pheochromocytoma, secretory, with VIPoma, treatment , opioids , watery,  MEN1,  Zollinger-Ellison syndrome, Diastrophic dysplasia, children with, growth standards , Diatrizota, iodine content , Diazepam.   Benzodiazepine(s) effects  endocrine function  values,  thyroid function parameters, Diazepam-binding           inhibitors,  Diazoxide diabetogenic properties , effects  endocrine function  values, oral preparation (Proglycem) actions , adverse effects  side effects , dosage  administration , indications , preparations , parenteral, preparation (Hyperstat IV, Diazoxide Injection) actions , adverse effects  side effects , dosage  administration , indications , preparations , therapy with  congential hyperinsulinism,  hyperinuslinism  infancy          childhood,  insulinomas, Dibasicaminoaciduria, organ-specific involvement , Dibenzyline.  Phenoxybenzamine Dibromochloropropane, toxic effects , DIC.  Disseminated intravascular coagulation Dicarboxylic acid, production ,  defects  carnitine metabolism,  fatty acid oxidation defects, Dicarboxylicaminoaciduria, Dicentric chromosome, Dichlorodiphenyldichloroethane, toxic effects Dichlorodiphenyltrichloroethane, toxic effects , Dichlorphenamide.  Carbonic anhydrase inhibitors Diclofenac sodium.   Nonsteroidal anti-inflammatory drugs  arachidonic acid metabolism,  cyclooxygenase activity, effects  endocrine function  values, Didanosine (ddI) effects  endocrine function  values, therapy with, endocrinologic side effects , indications , DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, deafness), Didronel.  Etidronate disodium Diencephalic epilepsy, Diencephalic syndrome ( infancy), clinical features , pathophysiology , prognosis , radiologic findings , signs  symptoms , treatment , Dienogest, Diet(s) atherogenic potential ,  breast cancer, calorie-restricted,  obesity,  cardiovascular disease prevention,  cystathionine synthase deficiency,  diabetes management,  childhood  adolescence,  diabetes prevention,  eating disorders,  endocrine test results, fad, hazards ,  gestational diabetes, high-calcium,  hyperparathyroidism, high-carbohydrate,  glucose tolerance, high fiber, high protein, low-carbohydrate, renin-angiotensin system activity ,  hyperlipoproteinemia,  hyperparathyroidism,  hypertriglyceridemia management, lipid-lowering,  diabetes, liquid protein, low-calcium,  hyperparathyroidism, low-carbohydrate, low-cholesterol, low-fat, low-protein,  diabetic neogrioatgtm “Mediterranean,”  obesity,  phenylketonuria,  phytosterolemia, step 1, step 2,  urea cycle disorder, “usual” American, vegetarian lacto-lacto-ovo-total, vegan, very-low-calorie, weight-loss,  obesity, successful, Diet  Reinfarction Trail (DART), Dietary analysis, computer databases , Dietary fiber.  Fiber (dietary) Dietary reference intakes, Dietary Supplement Health  Education Act  Diethylnitrosamine, pulmonary neuroendocrine cell hyperlasia caused by, Diethylstilbestrol (DES)  carcinogenesis, cardiovascular toxicity ,  clear cell adenocarcinoma,  vagina or cervix, cutaneous effects , effects  endocrine function  values, exposure ,  utero,  cervical cancer,  hirsutism,  infertility, perinatal effects , aminal models ,  prostate cancer, after relapse,  reproductive tract anomalies, Diethylstiblestrol diphosphate (Stilphostrol),  prostate cancer, after relapse, DiFerrante syndrome, Diffuse neuroendocrine system (DNES), biogenic amines , cells , chemoreceptive, closed, enzyme staining , formaldehyde-induced fluroescence , immunohistochemistry , localization , morphology , neurofilaments , open, organoid clusters , secretory granules , silver staining , tissue distribution , ultrastructure , central division , clinical relevance ,  control  cellular growth, dysplasia ,  gut, historical perspective , hyperplasia , neoplasia , peptide receptors , neuroendocrine markers , paracrine secretion , peptide content , growth modulatory effects , peripheral dvision , physiologic role , tumors , Diffuse peptide hormone system, characteristics , Diflunisal.   Salicylate(s) effects  endocrine function  values, DiGeorge syndrome, treatment , thymosin alfa, , Digestion, cephalic phase , Digit(s), arthralgia ,  paraneoplastic syndromes, Digitalis  glucocorticoid, interactions , intoxication,  magnesium deficiency, therapy with,  heart failure  hyperthyroidism, toxicity , hypokalemia-induced, Digital vasospasm, bromocriptine-related, Digitoxin.  Digoxin Diglyceride(s), Diglyceride lipase, Digoxin antibody , effects  endocrine function  values, metabolism ,  hypothyroidism, Digoxin immune Fab, effects  endocrine function  values, Dihydrobiopterin synthase deficiency, Dihydrobiopterin synthase deficiency, Dihydrocaffeic acid  blood tests  pheochromocytoma,  catecholamine assays, Dihydrocortisol, Dihydropteridine reductase deficiency, Dihydrotachysterol (DHT, Hytakerol).   Vitamin D (vitamin D3) dosage  administration , gel formulation, indications ,  male puberty, therapy with               hypocalcemia,  osteomalacia, preparations , Dihydrotestosterone, chemical structure ,  females alopecia , hair growth , hirsutism , during menstrual cycle, normal serum levels, as serum marker  androgenicity, formation ,  gynecomastia, reference values ,  reproductive embryology,  spermatogenesis, testicular function ,  laboratory evaluation , Dihydroxymandelic acid (DHMA), structure , Dihydroxyphenlacetic acid (DOPAC) assays , plasma / serum level , structue , Dihydroxyphenylalanine (DOPA) assays , plasma / serum level , structue , synthesis , urinary,  infants  children, age-related changes , Dihydroxyphenylglycol (DHPG) assays , plasma / serum level , structure , synthesis , 5alfa-Dihydroxytestosterone, 1,25-Dihydroxyvitamin D (1,25-dihydroxyvitamin D3), aging , analogs,  PTH secretion , bone,  calcium balance, circulating half-life , clinical significance , deficiency , endocrine effects ,  hypercalcemia  granulomatous disease,  idiopathic infantile hypercalcemia, immune functions ,  intestinal membrane lipids, intestinal response , assessment  ,  lever disease,  magnesium absorption,  meternal-fetal-placental unit, mechanism  action , metabolism ,  ,  osteocalcin gene transcription,  osteoclast function,  osteoporosis, parathyroidal effects ,  parathyroid hormone secretion,  phosphate homeostasis, plasma / serum level ,  anorexia nervosa,  autosomal recessive 1 alfa-hydroxylase deficiency,  differential diagnosis  hypocalcemia, direct assay ,  humoral hypercalcemia  malignancy,  hypocalcemic magnesium deficiency,  hypoparathyroidism,  osteomalacia,  idiopathic juvenile osteoporosis,  osteopetrosis,  pregnancy,  primary hyperparathyroidism,  rickets,  vitamin D resistance,  X-linked hypophosphatemic rickets, production ,  benign familial “idiopathic” hypercalciuria, calcium intake , daily amount , extrarenal,  hypophosphatemic osteomalacia, with lymphoma,. parathyroid hormone , phosphate intake , placental, by pulmonary alveolar macrophages, renal, reference values , regulation , resistance , biochemical characteristics ,  skiin, synthesis , cutaneous, renal, PTH , therapy with  autosomal recessive 1 alfa-hydroxylase deficiency,  glucocorticoid-induced osteoporosis,  hypocalcemia  pregnancy,  hypoparathyroidism, during febrile illness,  serum calcium levels,  osteomalacia,  osteopetrosis, preparations ,  renal osteodystrophy,  steroid-induced osteoporosis,  X-linked hypophosphatemic rickets, 24-25-Dihydroxyvitamin D (24,25-dihydroxyvitamin D3), maternal-fetal, measurement , normal range , production , reference values , skeletal effects , 25-Dihydroxyvitamin D, reference values , 25,26-Dihydroxyvitamin D measurement , normal range , production , 1,25-Dihydroxyvitamin D (1,25-dihydroxyvitamin D3) receptor(s), defects,  hereditary vitamin D resistance,  parathyroid cells, Diiodotyrosine (DIT),   thyroid hormone synthesis, Dilantin,  hypothalamic-pituitary-thyroid axis, Diltiazem, effects  endocrine function  values, Dimenhydrinate, effects  endocrine function  values, Dimercaprol, effects  endocrine function  values, Dimethisterone,  virilization, 3,5-Dimethyl-3’-isopropyl-L-thyronine, DIMIT, 2,4-Dinitrophenylhydrazine test,  amino-acid disorders, 3alfa-Diol-G, Dioxin effects  thyroid gland, toxic effects , Diphenhydramine.   Antihistamines effects  endocrine function  values, Diphenylhydantoin, osteomalacia caused by, 2,3-Diphosphoglycerate  diabetes,  diabetic ketoacidosis, red-cell, reduced,  hypophosphatemia, Diphtheroids, pituitary abscess caused by, Diploid number , chromosomes, Diplopia  diabetic ophthalmoplegia,  empty sella syndrome,  Graves disease, with pituitary adenoma, Diplotene stage,  meiosis, Direct calorimetry, Disaccharides, energy intake from, Disease association, Disopyramide, effects  endocrine

Best Viewable in 800X600 resolution and IE5 + and True Color (24 bit.)
Any Comments and suggestions - contact Web Specialist / Web Master
GPH InfoNet - A Great Way to Net
Or Visit Us at
GPH InfoNet